期刊文献+

老年人心力衰竭的病理生理机制探索新动向 被引量:8

New trends of pathophysiological mechanism of heart failure in the elderly
下载PDF
导出
摘要 心力衰竭(简称心衰)是老年人群中最常见的心血管疾病之一。本文综述了老年人心衰病理生理机制的特点;评价了交感神经过度激活、能量代谢重构在心衰中的作用及肾脏去神经术或曲美他嗪、辅酶Q10等药物治疗措施的疗效;同时介绍了肺动脉高压、心室一动脉偶联僵硬、系统性炎症状态等机制在射血分数保留心衰发生发展中的作用。 Heart failure (HF) is one of the most common cardiovascular diseases in the elderly. The article reviewed the pathophysiological mechanisms of HF in the elderly, revealed the roles of excessive sympathetic activation and energy metabolic remodeling in the development of HF, and evaluated the efficacy of renal denervation, and drugs such as trimetazidine and coenzyme Q10. Meanwhile, we also introduced the roles of pulmonary artery hypertension, ventricular-arterial coupling stiffness and systemic inflammation in the development and progress of HF with preserved ejection fraction.
出处 《中华老年多器官疾病杂志》 2014年第9期648-651,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 中央高校基本科研业务费专项资金资助华中科技大学自主创新研究基金项目(2014QN057)
关键词 心力衰竭 交感神经激活 肾脏去神经术 能量代谢重构 高血压 肺性 心室动脉偶联 heart failure sympathetic activation renal denervation energy metabolic remodeling hypertension, pulmonary ventricular-arterial coupling
  • 相关文献

参考文献15

  • 1顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1275
  • 2Forman DE, Ahmed A, Fleg JL. Heart failure in very old adults[J]. Curr Heart Fail Rep, 2013, 10(4): 387-400.
  • 3Kitzman DW, Nicklas B, Kraus WE, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction[J]. Am J Physiol Heart Circ Physiol, 2014, 306(9): H1364-H1370.
  • 4Davies JE, Manisty CH, Petraco R, et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study[J]. Int J Cardiol, 2013, 162(3): 189-192.
  • 5Liu LC, Damman K, Lipsic E, et al. Heart failure highlights in 2012-2013[J]. Eur J Heart Fail, 2014, 16(2): 122-132.
  • 6Fragasso G, Rosano G, Baek SH, et al. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an International Multicentre Retrospective Cohort Study[J]. Int J Cardiol, 2013, 163(3): 320-325.
  • 7Anon. First drug to improve heart failure mortality in over a decade: coenzyme Q10 decreases all-cause mortality by half in randomized double blind trial[J]. Eur Heart J, 2013, 34(32): 2496-2497.
  • 8Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension[J]. N Engl J Med, 2001, 344(1): 17-22.
  • 9Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients[J]. Chest, 2007, 131(1): 94-100.
  • 10Lam CS, Borlaug BA, Kane GC, et al. Age-associated increases in pulmonary artery systolic pressure in the general population[J]. Circulation, 2009, 119(20): 2663-2670.

二级参考文献1

  • 1叶任高 主编.内科学:第5版[M].北京:人民卫生出版社,2001.824.

共引文献1274

同被引文献119

  • 1李仁祧,任宏生.心力衰竭的评估标准及常用检测方法[J].山东医药,2005,45(13):68-69. 被引量:23
  • 2杨建峰,魏经汉.慢性心力衰竭患者血清IL-1β、TNF-α水平及临床意义[J].实用全科医学,2007,5(11):954-955. 被引量:14
  • 3王士雯,吴海云.老年人多病因心力衰竭:多种病因和合并疾病在老年人心力衰竭发生和发展中的作用[J].中华老年多器官疾病杂志,2007,6(6):373-376. 被引量:14
  • 4无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3662
  • 5Robertson J, McElduff P, Pearson SA, et al. The health services burden of heart failure: an analysis using linked population health data-sets[J].BMC Health Serv Res, 2012, 12:103.
  • 6Kawase Y,Kadota K, Nakamura M, et al. Low systolic blood pressure on admission predicts mortality in patients with acute decompensated heart failure due to moderate to severe aortic stenosis[J]. Circ J, 2014,78 (10) : 2455-- 2459.
  • 7Fujino T, Kinugawa K, Hatano M, et al. Low blood pressure, low serum cholesterol and anemia predict early necessity of ventricular assist device implantation in patients with advanced heart failure at the time of referral from non- ventricular assist device institutes[J]. Circ J, 2014,78 (12) : 2882--2889.
  • 8Cunha FM,Loureno P,Couto M,et al. Is the blood pressure paradox observed in all heart failure patients ? [J]. Biomed Res Int, 2013,20(4) : 1-- 7.
  • 9Fonarow GC, Albert NM, Curtis AB, et al. Incremental reduction in risk of death associated with use of guideline- recommended therapies in patients with heart failurea nested case-control analysis of IMPROVE HF[J]. J Am Heart Assoc,2012,1 (1) 16--26.
  • 10Jin C, Liu M, Sun J, eta. The prevalence and prognosis of resistant hypertension in patients with heart failure[J]. PLoS One,2014,9(12) e114958.

引证文献8

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部